About This Event
Innate Pharma (Nasdaq: IPHA), a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Hervé Brailly, CEO, rings the Closing Bell.